INVESTIGATIVE REPORTER CAREY GILLAM OFFERS INSIGHT INTO THE DUBIOUS MONSANTO 'ROUNDUP' SETTLEMENT. In the landmark lawsuit, "Organic Seed Growers and Trade Association et al v. Monsanto" (Jim is President of OSGATA) we learned to never trust Monsanto.
Those lessons were again valuable this week when Monsanto (acquired two years ago by Bayer AG) rolled out its suspicious proposed self-serving sweetheart settlement.
Stellar researcher Carey Gillam of 'US Right-to-Know' explains that we have good reason to be skeptical of this backroom deal hammered out by Monsanto and sketchy johnny-come-lately lawyers who seek to snatch justice out of the courts and transfer it into the domain of five hand-picked "scientists."
Expect to see a challenge mounted by the authentic and dedicated attorneys who pioneered protecting the interests of citizens harmed by Monsanto's deadly products. Caleb, Megan & Jim
"A plan to delay any new Roundup cancer claims for years and shift the key question of whether or not the weed killer causes cancer from a jury to a hand-picked panel of scientists faces potential opposition from some of the plaintiffs’ attorneys who initiated and led the mass tort claims against Roundup maker Monsanto, sources close to the litigation said.
Several members of the lead law firms who won three out of three trials pitting cancer patients against Monsanto are considering challenging the terms of a proposed 'class action' settlement negotiated between Monsanto owner Bayer AG and a small team of lawyers who have not previously been at the forefront of the Roundup litigation, the sources said…
"In each of the trials held to date, juries found that the weight of scientific evidence proved that Roundup exposure caused the plaintiffs to develop non-Hodgkin lymphoma (NHL) and that Monsanto covered up the risks. But under the proposal that question would go to a five-member 'science panel,' not a jury.
“'It’s basically depriving a plaintiff of their constitutional right to a jury trial,' said one source close to the litigation."
A plan to delay any new Roundup cancer claims for years and shift the key question of whether or not the weed killer causes cancer from a jury to a hand-picked panel of scientists faces potential opposition from some of the plaintiffs’ attorneys who initiated and led the mass tort claims against R…